Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study

被引：0
|
作者：
Han Eol Jeong
Sohee Park
Yunha Noh
Sungho Bea
Kristian B. Filion
Oriana H. Y. Yu
Seung Hun Jang
Young Min Cho
Dong Keon Yon
Ju-Young Shin
机构：
[1] Sungkyunkwan University,School of Pharmacy
[2] Sungkyunkwan University,Department of Biohealth Regulatory Science
[3] Biostatistics,Departments of Medicine and of Epidemiology
[4] and Occupational Health,Centre for Clinical Epidemiology
[5] McGill University,Division of Endocrinology and Metabolism
[6] Lady Davis Institute,Division of Pulmonary, Allergy, and Critical Care Medicine, College of Medicine
[7] Jewish General Hospital,Department of Internal Medicine
[8] Jewish General Hospital,Department of Translational Medicine
[9] McGill University,Department of Internal Medicine
[10] Hallym University Sacred Heart Hospital,Institute On Aging
[11] Hallym University,Department of Pediatrics
[12] Seoul National University College of Medicine,Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Sciences & Technology (SAIHST)
[13] Seoul National University College of Medicine,undefined
[14] Seoul National University Hospital,undefined
[15] Seoul National University,undefined
[16] Medical Science Research Institute,undefined
[17] Kyung Hee University College of Medicine,undefined
[18] Kyung Hee University Medical Center,undefined
[19] Kyung Hee University College of Medicine,undefined
[20] Sungkyunkwan University,undefined
来源：
BMC Medicine | / 21卷
关键词：
Sodium-glucose cotransporter 2 inhibitors; Respiratory effectiveness; Type 2 diabetes; Population-based cohort;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Sodium-glucose cotransporter 2 inhibitors and risk of fractures in postmenopausal women with type 2 diabetes: A nationwide cohort study
    Ko, Hwa Yeon
    Bea, Sungho
    Jeong, Han Eol
    Park, Sohee
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 81 - 82
  • [22] Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale
    Yassin, Sayf A.
    Aroda, Vanita R.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 923 - 937
  • [23] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes
    Abrahami, Devin
    Douros, Antonios
    Yin, Hui
    Yu, Oriana H. Y.
    Azoulay, Laurent
    DIABETES CARE, 2019, 42 (09) : E150 - E152
  • [24] Psychiatric disorders in patients with type 2 diabetes mellitus on sodium-glucose cotransporter-2 inhibitors—a nationwide retrospective cohort study
    Wei-Syun Hu
    Cheng-Li Lin
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 575 - 581
  • [25] Acute kidney injury in Japanese type 2 diabetes patients receiving sodium-glucose cotransporter 2 inhibitors: A nationwide cohort study
    Horii, Takeshi
    Oikawa, Yoichi
    Kunisada, Narumi
    Shimada, Akira
    Atsuda, Koichiro
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (01) : 42 - 46
  • [26] New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors
    Jung, Chan-Hee
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (02) : 339 - 341
  • [27] Sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors and the risk of heart failure: A nationwide cohort study of older adults with diabetes mellitus
    Fralick, Michael
    Colacci, Michael
    Thiruchelvam, Deva
    Gomes, Tara
    Redelmeier, Donald A.
    DIABETES OBESITY & METABOLISM, 2021, 23 (04): : 950 - 960
  • [28] Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors: The Hong Kong Diabetes Study
    Tse, Gary
    Lee, Sharen
    Liu, Tong
    Zhou, Jiandong
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (02) : 391 - 392
  • [29] Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors: The Hong Kong Diabetes Study
    Gary Tse
    Sharen Lee
    Tong Liu
    Jiandong Zhou
    Cardiovascular Drugs and Therapy, 2024, 38 : 391 - 392
  • [30] Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes
    Chang, Hsien-Yen
    Singh, Sonal
    Mansour, Omar
    Baksh, Sheriza
    Alexander, G. Caleb
    JAMA INTERNAL MEDICINE, 2018, 178 (09) : 1190 - 1198
12345